Digestive Disease & Surgery Institute Outcomes
Gallbladder and Abdominal Surgery
Small Bowel Obstruction
Small Bowel Obstruction 30 Day Outcomes (Elective and Non-Elective Cases)
2022 - 2023
| 30 Day Outcomes | 2022 % (N=54) | 2023 % (N=50) |
|---|---|---|
| Fascial Dehiscence / Enterocutaneous Fistula | 0 | 0 |
| Missed Enterostomy | 0 | 0 |
| Unplanned Reoperation | 3 | 2 |
| Procedural Re-Intervention (CD III)5* | 1 | 6 |
| Readmission | 12 | 6 |
Data Source: Cleveland Clinic, Digestive Disease Institute Quality Collaborative
*Any procedural intervention as defined by Clavien Dindo III – “Requiring surgical, endoscopic or radiological intervention"
Data include Main Campus, Fairview, and Hillcrest
Small Bowel Obstruction Intraoperative Outcomes
2022 - 2023
2022 % (N) | 2023 % (N) | |
|---|---|---|
| MIS Conversion, Non-Elective | 25 (16) | 20 (35) |
| MIS Conversion, Elective | 33 (6) | 0 (5) |
| Unplanned Enterotomy | 1 (349) | 1 (407) |
Data Source: Cleveland Clinic, Digestive Disease and Surgery Institute Quality Collaborative
MIS = minimally invasive surgery
Data include Main Campus, Fairview, and Hillcrest
